Impact of timing HAART-initiation on immune status and clinical course in the cohort of the German Competence Network for HIV/AIDS

A. Plettenberg, N.H. Brockmeyer, B. Haastert, S. Dupke, K. Schewe, M. Rausch, M. Hower, G. Arendt, K. Jansen & Competence Network For HIV/AIDS
Background: HAART has dramatically reduced morbidity and mortality in HIV-infected patients (pts) but optimal time of therapy initiation is still unknown. Several studies investigating this issue showed inconsistent results. Our study investigated whether there is a clinical benefit as to treated patients[for full text, please go to the a.m. URL]